## UHS: Universal Health Services, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -4.3% below STRENGTH zone (3.0-6.0%); PEG 1.87 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($217.85)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Arrowstreet Capital Limited Partnership Cuts Position in Universal Health Services, Inc. $UHS**
- Source: MarketBeat | 20251204T020951 | Neutral | Relevance: 100%
- Arrowstreet Capital Limited Partnership reduced its stake in Universal Health Services (NYSE:UHS) by 13.8% in Q2, selling 173,532 shares, but still holds over a million shares valued at approximately $196.6 million. Despite this reduction, other large institutional investors like Virginia Retirement Systems and Norges Bank initiated new positions, maintaining institutional ownership around 86.05%. The company reported strong Q2 earnings with EPS significantly beating estimates and declared a quarterly dividend of $0.20 per share.

**2. Distillate Capital Partners LLC Trims Position in Universal Health Services, Inc. $UHS**
- Source: MarketBeat | 20251203T041039 | Somewhat-Bullish | Relevance: 100%
- Distillate Capital Partners LLC reduced its stake in Universal Health Services (NYSE:UHS) by 5.5% in Q2, selling 4,477 shares, though institutional ownership remains high at 86.05%. Despite this, several other institutions significantly increased their positions. Universal Health Services reported strong quarterly earnings, beating estimates, declared a quarterly dividend, and holds a consensus "Hold" rating with a target price of $232.64.

**3. HCAâ€™s Cash Machine Looks Cheap After A Healthy Run**
- Source: Finimize | 20251203T145120 | Neutral | Relevance: 74%
- HCA Healthcare, the largest for-profit hospital operator in the U.S., has shown strong recent performance with a 56.6% total return over 12 months and raised full-year guidance for 2025. Despite policy risks and labor cost inflation, its robust cash generation, strong margins, and perceived valuation discount make it an appealing opportunity for long-term investors, though the stock carries risks associated with leverage and regulatory uncertainty.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Guggenheim | $274 | $253 | +8% |
| 2025-11-13 | Wells Fargo | $259 | $249 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Guggenheim | main | Buy |
| 2025-11-13 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($11.07M) |
| Sells | 3 ($30.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-3.4%)
- First Eagle Investme: 8.4% (+0.0%)
- Blackrock Inc.: 8.0% (-11.9%)
- State Street Corpora: 4.7% (-3.1%)
- FMR, LLC: 3.8% (+0.1%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-6.0% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $31M sold (3 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.87 elevated, pricing in significant growth expectations. Analyst sentiment positive (2 raises, avg +6%). Insider selling cluster ($30.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $14.5B |
| Beta | 1.27 |
| 52W Range | $152.33 - $246.33 |
| Short Interest | 5.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.87 |
| Forward P/E | 9.8 |
| Current P/E | 10.6 |
| YoY Growth | 8.0% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 1.6% to -4.3% (-6.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.3pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.22x) but short-term weakness (below SMA20). MACD histogram bearish (-1.03), momentum weakening. RSI neutral at 53. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -4.35% (CS: 8) | Weak |
| RSI_14 | 53.0 | Neutral |
| MACD Histogram | -1.03 | Bearish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 1.058x | Above |
| vs SMA200 | 1.220x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $230.59
- **Stop Loss:** $217.85 (5.5% risk)
- **Target:** $243.33 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 39
- **Position Value:** $8,993.01
- **Portfolio %:** 8.99%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-25 (Est: $5.89)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.95 | $5.69 | +14.9% |
| 2025Q2 | $4.96 | $5.35 | +8.0% |
| 2025Q1 | $4.36 | $4.84 | +11.1% |
| 2024Q4 | $4.18 | $4.92 | +17.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*